Thrombotic thrombocytopenic purpura with juvenile systemic lupus erythematosus: successful treatment with caplacizumab and rituximab

被引:0
|
作者
Tadafumi Yokoyama [1 ]
Takuya Mimura [1 ]
Hiroki Tanaka [1 ]
Ria Kasahara [2 ]
Masaaki Usami [1 ]
Yusuke Matsuda [1 ]
Toshihiro Fujiki [1 ]
Taizo Wada [1 ]
机构
[1] Kanazawa University Hospital,Department of Pediatrics
[2] National Hospital Organization,Department of Pediatrics
[3] Kanazawa Medical Center,undefined
关键词
Thrombotic thrombocytopenic purpura; Systemic lupus erythematosus; ADAMTS13 inhibitor; Caplacizumab; Rituximab;
D O I
10.1186/s12969-024-01049-0
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Caplacizumab for relapsing thrombotic thrombocytopenic purpura
    Kaczmarek, Veronika
    Holle, Johannes
    Astudillo, Rebekka
    Kempf, Caroline
    Baler, Philip
    Mueller, Dominik
    PEDIATRIC NEPHROLOGY, 2019, 34 (09) : 1625 - 1628
  • [22] SYSTEMIC LUPUS ERYTHEMATOSUS COMPLICATED BY THROMBOTIC THROMBOCYTOPENIC PURPURA
    Gerosa, M.
    Gualtierotti, R.
    Pisati, M.
    Meroni, P. L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S120 - S121
  • [23] Fulminant thrombotic thrombocytopenic purpura in systemic lupus erythematosus
    Jorfén, M
    Callejas, JL
    Formiga, F
    Cervera, R
    Font, J
    Ingelmo, M
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1998, 27 (01) : 76 - 77
  • [24] Successful treatment of relapsing autoimmune thrombotic thrombocytopenic purpura with rituximab
    Sankararaman, Senthilkumar
    Jeroudi, Majed
    Ibrahim, Hassan
    PEDIATRICS INTERNATIONAL, 2014, 56 (06) : 914 - 918
  • [25] The features and risk factors of thrombotic thrombocytopenic purpura in systemic lupus erythematosus
    Hang Ma
    Yujie He
    Shanshan Li
    Yingchao Yang
    Liubin Huo
    Tianfang Li
    Orphanet Journal of Rare Diseases, 20 (1)
  • [26] Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura
    Reid, Justin H.
    Durant, Karin M.
    Chen, Sheh-Li
    Perissinotti, Anthony J.
    King, Richard
    Khoriaty, Rami
    Marini, Bernard L.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (07) : 1695 - 1702
  • [27] Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus
    Musio, F
    Bohen, EM
    Yuan, CM
    Welch, PG
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1998, 28 (01) : 1 - 19
  • [28] Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case and review
    Abdullah Sakarcan
    James Stallworth
    Pediatric Nephrology, 2001, 16 : 672 - 674
  • [29] Development of systemic lupus erythematosus 5 years after onset of thrombotic thrombocytopenic purpura
    Shingu, Keita
    Funakoshi, Yasutomo
    Ito, Nobuhiro
    Okada, Masahiko
    Moriuchi, Hiroyuki
    PEDIATRICS INTERNATIONAL, 2017, 59 (08) : 943 - 944
  • [30] Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
    Scully, M.
    Cataland, S. R.
    Peyvandi, F.
    Coppo, P.
    Knobl, P.
    Hovinga, J. A. Kremer
    Metjian, A.
    de la Rubia, J.
    Pavenski, K.
    Callewaert, F.
    Biswas, D.
    De Winter, H.
    Zeldin, R. K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (04) : 335 - 346